New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Prestige Consumer Healthcare Inc.
PBH
Shape
US Flag

NYSE

4B

Medical - Distribution

Next Earning date - 07 Nov 2024

4B

Medical - Distribution

Next Earning date - 07 Nov 2024

73.77USD
Shape0.94 ( 1.29%)
Market Open
favorite-chart

Relative Strenght

23
favorite-chart

Volume Buzz

-88%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

3%

Quote Panel

Shape
Updated October 25, 2024
1W 3.14 % 1M 3.07 % 3M 4.05 % 1Y 23.27 %

Key Metrics

Shape
  • Market Cap

    3.66B


  • Shares Outstanding

    49.56M


  • Share in Float

    48.87M


  • Dividende

    0


  • Earning Date

    07 Nov 2024


  • Price Target

    73.77


  • Average Volume

    244260


  • Beta

    0.473


  • Range

    56.61-75.8


  • Industry

    Medical - Distribution


  • Website

    https://www.prestigebrands.com


  • Sector

    Healthcare


Fundamentals

Shape

18.34x

P/E Ratio

3.24x

P/S Ratio

2.16x

P/B Ratio

0.7

Debt/Equity

18.4%

Net Margin

$4.1

EPS

How PBH compares to sector?

P/E Ratio

Relative Strength

Shape

PBH

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$1B

Shape324%

2025-Revenue

$4.48

Shape357%

2025-EPS

$380M

Shape374%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Jefferies

downgrade

Previous: Buy

2024-09-23

Now: Hold

Canaccord Genuity

initialise

Previous: Not converted

2022-11-17

Now: Buy

Jefferies

upgrade

Previous: Not converted

2022-05-10

Now: Buy

Oppenheimer

upgrade

Previous: Not converted

2022-05-09

Now: Outperform

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

1.02
vs 1.02

Q4.22

arrow
arrow

+5%

1.04
vs 0.99

Q1.23

arrow
arrow

+18%

1.07
vs 0.91

Q2.23

arrow
arrow

-3%

1.06
vs 1.09

Q3.23

arrow
arrow

+5%

1.07
vs 1.02

Q4.23

arrow
arrow

+2%

1.06
vs 1.04

Q1.24

arrow
arrow

-8%

0.98
vs 1.07

Q2.24

arrow
arrow

-15%

0.9
vs 1.06

Q3.24

arrow
arrow

+1%

1.08
vs 1.07

Q4.24

arrow
arrow

+14%

1.21
vs 1.06

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+5%

289.3M  vs 276.2M

Q4.22

arrow
arrow

+0%

275.5M  vs 274.5M

Q1.23

arrow
arrow

+7%

285.9M  vs 266.9M

Q2.23

arrow
arrow

+1%

279.3M  vs 277.1M

Q3.23

arrow
arrow

-1%

286.3M  vs 289.3M

Q4.23

arrow
arrow

+3%

282.7M  vs 275.5M

Q1.24

arrow
arrow

-3%

277M  vs 285.9M

Q2.24

arrow
arrow

-4%

267.1M  vs 279.3M

Q3.24

arrow
arrow

-1%

282.2M  vs 286.3M

Q4.24

arrow
arrow

+2%

289.4M  vs 282.7M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

+3%

0.03
vs 0.03

Q4.22

arrow
arrow

+3%

0.03
vs 0.03

Q1.23

arrow
arrow

-17%

-0.17
vs 0.03

Q2.23

arrow
arrow

+4%

0.04
vs -0.17

Q3.23

arrow
arrow

+3%

0.03
vs 0.04

Q4.23

arrow
arrow

+3%

0.03
vs 0.03

Q1.24

arrow
arrow

+3%

0.03
vs 0.03

Q2.24

arrow
arrow

+3%

0.03
vs 0.03

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

280

280
vs 284

-1%

Q4.22

arrow
arrow

290

290
vs 280

4%

Q1.23

arrow
arrow

285

285
vs 290

-2%

Q2.23

arrow
arrow

279

279
vs 285

-2%

Q3.23

arrow
arrow

281

281
vs 279

1%

Q4.23

arrow
arrow

290

290
vs 281

3%

Q1.24

arrow
arrow

312

312
vs 290

8%

Q2.24

arrow
arrow

305

305
vs 312

-2%

Earnings Growth

Latest News